You are here

• Home
• Therapy Areas
• Cardiovascular

• A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Ascending Oral Doses of AZD1656 in Japanese Healthy Male Volunteers

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Aug 5, 2008

Study Name

D1020C00003

Study Id

D1020C00003

ClinicalTrials.gov ID

NCT00741689

Recruiting Status

Closed

Protocol Status

Not Available

Report

Sep 30, 2009

• D1020C00003.pdf (596 KB)

Page tools

• Print
• Bookmark this page